David Elsley
Tracked across 1 events · 6 articles · First seen Sep 23, 2026 · Last active Sep 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Cardiol Therapeutics Inc. announced on September 23, 2026 that its pivotal Phase III MAVERIC trial of CardiolRx for recurrent pericarditis reached its original 110-patient enrollment target ahead of end-of-September guidance. Following a blinded review showing…
Impact: As President and CEO, he publicly framed the lower-than-expected recurrence rate as encouraging and explained the rationale for expanding enrollment to preserve statistical power.
Sep 23, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David Elsley live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard